Symptoms & Early Warning Signs
Common indicators and clinical warning signs
Note: Early-stage liver cancer often has no symptoms. Symptoms usually appear when the cancer is advanced or when there's underlying liver disease. Regular monitoring is important for high-risk individuals (cirrhosis, hepatitis B/C).
Diagnosis Pathway
Step-by-step clinical evaluation and staging workflow
Medical history and physical examination
Blood tests (liver function tests, AFP tumor marker)
Imaging tests (ultrasound, CT scan, or MRI of liver)
Liver biopsy (if needed for confirmation)
Staging assessment (BCLC staging system)
Assessment of liver function (Child-Pugh score)
Evaluation for underlying liver disease (hepatitis, cirrhosis)
Staging Explained
How tumor size, lymph node involvement, and metastasis are graded
Early stage: single tumor or up to 3 tumors <3cm, good liver function, good performance status
Intermediate: multiple tumors or larger tumors, good liver function, no symptoms
Advanced: tumor has spread to blood vessels, lymph nodes, or distant sites, or patient has symptoms
End-stage: very poor liver function or very poor overall health
Treatment Options
Standard of care modalities according to NCCN clinical guidelines
Surgery (Resection)
Removal of part of the liver containing the tumor. Only possible if tumor is small, confined to one area, and liver function is good. Requires healthy liver tissue remaining.
Liver Transplant
Replacement of entire liver. Best option for early-stage HCC in patients with cirrhosis. Requires meeting specific criteria (Milan criteria or similar) and being on transplant list.
Ablation
Destroying tumors without surgery. Methods: radiofrequency ablation (RFA), microwave ablation, or ethanol injection. Used for small tumors (<3-5cm) that can't be surgically removed.
TACE (Transarterial Chemoembolization)
Procedure that delivers chemotherapy directly to the tumor and blocks its blood supply. Used for intermediate-stage HCC. May be repeated multiple times.
Targeted Therapy
Oral medications: sorafenib, lenvatinib (first-line), regorafenib, cabozantinib (second-line). Used for advanced HCC. Can slow tumor growth and extend survival.
Immunotherapy
Atezolizumab + bevacizumab is first-line for advanced HCC. Other options: nivolumab, pembrolizumab. Used for advanced disease that can't be treated with surgery or local therapies.
Treatment Cost Comparisons
Transparent out-of-pocket benchmarks for India and US healthcare centers
Treatment Cost in India
- Liver resection surgery: ₹5-15 lakhs
- Liver transplant: ₹25-50 lakhs
- Ablation (RFA): ₹2-5 lakhs
- TACE procedure: ₹1.5-4 lakhs (per session, may need multiple)
- Targeted therapy: ₹60,000 - ₹3 lakhs per month
- Immunotherapy: ₹1-4 lakhs per cycle
- Complete treatment: ₹8-50 lakhs (depending on stage and type)
Treatment Cost in US
- Liver resection: $30,000 - $100,000
- Liver transplant: $500,000 - $1,000,000+
- Ablation: $15,000 - $50,000
- TACE: $20,000 - $60,000 (per session)
- Targeted therapy: $8,000 - $20,000 per month
- Immunotherapy: $10,000 - $20,000 per cycle
- Complete treatment: $60,000 - $1,000,000+
Frequently Asked Questions about Liver Cancer (HCC)
This guide provides verified clinical insights based on established oncological literature (NCCN, ASCO, ESMO). It is not a substitute for professional medical diagnosis or personalized treatment planning. Always consult your qualified oncology specialist before initiating treatment.